🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II pilot study of chemotherapy and surgery for children wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-10
Trial ID
NCT00186849
Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Status
Unknown
Location
Presidio Ospedaliero Spedali Civili di Brescia
Start Date
2013-11
Trial ID
NCT02099188
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The study is a first step of a process to establish the standard chemothera...
Status
Completed
Location
Cooperative Osteosarcoma Study Group
Start Date
2002-01
Trial ID
NCT02986503
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1997-09
Trial ID
NCT00003105
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-12
Trial ID
NCT00003776
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00652860
Treatments Being Tested
The purpose of this study is to improve outcome of high risk neuroblastoma ...
Status
Unknown
Location
Samsung Medical Center
Start Date
2015-04
Trial ID
NCT02771743
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested